4DS Memory Limited Overview
4DS Memory Limited is a Perth-headquartered, Silicon Valley-engineered semiconductor intellectual-property company that pioneered "Interface Switching ReRAM" — a non-filamentary, area-based resistive memory built on a praseodymium-calcium-manganese-oxide (PCMO) perovskite stack. For most of its 18-year history the company pursued a single, binary objective: scaling that cell to sub-20nm geometries to create a gigabit-class Storage Class Memory sitting between DRAM and NAND, with imec as fab partner and Western Digital's HGST as long-standing joint development partner. That objective was abandoned in 2025 after the 20nm Sixth Platform Lot suffered electrical shorting caused by etch residues. Today 4DS is repositioning around two assets: a validated 60nm PCMO ReRAM platform that it seeks to license into mature-node fabs (India is the priority market) and, via the pending Jenesys acquisition, an Edge-AI/autonomous-systems software stack intended to create an integrated computing-in-memory and neuromorphic computing platform.
Company's own description
The company's standard boilerplate (used in every ASX release through September 2026) describes 4DS as a semiconductor technology company with facilities in Silicon Valley, bringing high-bandwidth, high-endurance, persistent non-volatile memory to advanced CMOS process nodes; it states that its Interface Switching ReRAM offers tuneable persistence and low energy per bit for compute-intensive and AI processor workloads, that it was established in 2007, that it owns 34 granted US patents, and that it was the first company to develop PCMO ReRAM on an advanced CMOS node (source: 4DS ASX releases, e.g., Company Update 26 May 2026; Investor Webinar notice 1 Sep 2026).
Third-party profiles (MarketScreener) describe the memory cell as switching between a high-resistive state (HRS) and a low-resistive state (LRS), i.e., a resistive RAM where the switching is distributed across the interface area of the cell rather than through a conductive filament.
Following the 31 August 2026 Jenesys transaction, the company now describes its intended business as an integrated hardware-software platform combining its PCMO ReRAM with Jenesys's Edge-AI software and autonomous-systems capability, targeting computing-in-memory (CIM) and neuromorphic computing, while stating that its validated 60nm PCMO ReRAM platform remains a leading focus of its technology programme (source: 4DS "4DS to Acquire Jenesys", 31 Aug 2026, as reported by techpartner.news and Stockwire X).
Independent characterization
In substance, 4DS has been — and through FY2026 remained — a pre-commercial technology-development company with no product revenue. Its reported "revenue" (A$305k in FY2025; A$340k in FY2026) consists of interest income and other non-operating items rather than sales or licence fees (Appendix 4E FY2025 and FY2026; Quartr FY2026 summary). The economic model has always been "develop-then-monetize": fund R&D through equity raises, prove the technology on industrial-grade wafers (the "Platform Lots" fabricated at imec), and then monetize via (a) a licence/technology-transfer deal with a memory manufacturer, or (b) a corporate transaction (sale of the IP or the company). Shareholder commentary and the company's own 2021 updates explicitly framed a megabit chip "and/or a corporate transaction" as the target outcome (strawman.com reproduction of 2021 company update).
Revenue model mix
| Revenue stream | Status (FY2026) | Comment |
|---|---|---|
| Product sales | — | 4DS has never sold memory chips |
| Licensing / royalties | None to date | India licensing/technology-transfer pathway announced 12 May 2026; no binding licence disclosed |
| Services / NRE | — | — |
| Subscription / software | None to date (prospective via Jenesys Distributed Autonomy Stack) | Jenesys performance-rights milestones are defined on contracted licensing/deployment revenue (A$2M within 24 months; A$5M within 36 months) |
| Interest and other income | A$339,555 (FY2026); A$305,160 (FY2025) | Appendix 4E FY2026; Annual Report FY2025 |
Value-chain position
4DS sits at the very top of the semiconductor value chain — memory-cell and process IP — upstream of foundries/IDMs that would manufacture embedded or standalone memory, and of fabless chip designers who would integrate it. It relied on partners for every capital-intensive step: imec (Leuven, Belgium) for 300mm wafer fabrication of Platform Lots; Infineon Technologies LLC for test-chip design (Dec 2024 – Sep 2025); and HGST/Western Digital as a joint development partner since the mid-2010s. Post-Jenesys, the company aims to move one step downstream into system-level demonstration (software running on ReRAM-based compute-in-memory hardware) for autonomous systems.
Customer types and end-markets
Historical target customers: memory makers and storage companies (HGST/Western Digital), seeking Storage Class Memory for mobile devices and cloud data centres (company boilerplate 2019–2023; IBISWorld).
2023–2025 positioning: AI processors and "big data" workloads requiring high-bandwidth, high-endurance persistent memory (company boilerplate from 2023).
2026 positioning (mature node): industrial, automotive, defence and related embedded applications at 60–65nm, with Indian fabs, conglomerates and OEMs as licensing counterparties (Company Update, 12 May 2026).
2026 positioning (Jenesys): defence/dual-use autonomous systems — coordination of mixed fleets of unmanned vehicles across air, land, sea and space — via Jenesys's Distributed Autonomy Stack (techpartner.news; Stockwire X summary of 31 Aug 2026 release).
Strategy
Strategic themes (latest annual report and releases)
-
Capital discipline and value preservation. The September 2025 review was framed around deploying capital to maximize shareholder value; management concluded that further 20nm iterations would require materially more time and capital without certainty of meeting market performance benchmarks (Strategic Review release, 5 Sep 2025).
-
AI-enablement ecosystem. The December 2025 update said the review was focused on high-speed, low-energy data processing, advanced analytics and next-generation memory performance, with exploratory partner discussions (Strategic Review Development Update, 10 Dec 2025).
-
Mature-node commercialization (India). Commercialize the proven 60nm platform through licensing and technology transfer, embedded memory applications, R&D partnerships and OEM integration in India, which has committed more than A$25 billion to building sovereign semiconductor manufacturing (Company Update, 12 May 2026).
-
Hardware-software integration (Jenesys). Combine PCMO ReRAM with Edge-AI software to target CIM and neuromorphic computing through an integrated, capital-efficient pathway (4DS to Acquire Jenesys, 31 Aug 2026).
-
Retain the HGST relationship. The JDA was renewed in the September 2025 quarter; the next renewal meeting was deferred to August 2026 at HGST's request (June 2026 Quarterly). Outcome n/d.
Initiative register (last 24 months)
| Date | Initiative | Type | Target / status |
|---|---|---|---|
| 17 Dec 2024 | Infineon custom ReRAM test-chip design agreement (US$4.5M / 15 months) | Technology partnership | Terminated Sept 2025 |
| Jan–Feb 2025 | A$6M placement + A$2M SPP | Funding | Completed |
| H1 2025 | Sixth Platform Lot (20nm) with imec | R&D programme | Failed; root cause etch residues |
| 5 Sep 2025 | Three-month strategic pause and review | Restructuring | Completed; outputs = India + Jenesys |
| FY2026 | Reduction in director/executive pay; pause of non-essential activities | Cost programme | Delivered (FY2026 loss -84%) |
| 12 May 2026 | India mature-node commercialization pathway | New market | Business development stage |
| June 2026 | Executive Chairman India trip; meetings with two major Indian conglomerates | Business development | No binding agreement disclosed |
| 31 Aug 2026 | Jenesys acquisition + ~A$5M raise | M&A / new business | Targeted completion 5 Oct 2026 |
| Post-completion | Integration of Jenesys software (incl. Edge-AI models) with PCMO ReRAM hardware | Platform investment | Planned |
Management targets and guidance
No quantitative revenue or earnings guidance has been issued. The only quantified forward markers are the Jenesys performance-rights milestones, which (per summaries of the 31 Aug 2026 release) include tranches tied to at least A$2M of binding contracted revenue within 24 months and at least A$5M within 36 months from licensing, deployment or commercialization of the Distributed Autonomy Stack or related technology, excluding grants and one-off items. These function as de facto medium-term targets. ESG commitments: none disclosed.
Products & Services
4DS has no commercially shipping products. The "portfolio" below catalogs its technology platforms, development vehicles and (prospective) software assets.
Memory IP (sole current segment)
| Offering | Description | Key specifications / capabilities (as disclosed) | Target customer | Latest version / year | Pricing model |
|---|---|---|---|---|---|
| Interface Switching ReRAM (PCMO cell) | Area-based (non-filamentary) resistive memory using Pr0.7Ca0.3MnO3 perovskite; switches between high- and low-resistance states across the cell interface | Single-shot write time of 4.7ns; endurance up to 10^9 cycles demonstrated; tuneable retention ("persistence window"), refreshable within DRAM operating window; low energy per bit | Memory makers, AI-processor designers, mature-node fabs | Platform validated at 60nm (2023); 20nm attempt failed (2025) | Licensing / technology transfer (none signed) — rram-info.com; company releases |
| 60nm megabit array platform | Fully functioning megabit array with 60nm cells built on imec's megabit memory platform (Fourth Platform Lot) | First functioning megabit array demonstrated (FY2024 AGM address); repeated/optimised in Fifth Platform Lot | Mature-node fabs (India), embedded-memory licensees in industrial, automotive, defence | 2023–2024 | Licensing, technology transfer, R&D partnerships, OEM integration (Company Update 12 May 2026) |
| 20nm memory cell array (Sixth Platform Lot) | First attempt at scaled 20nm array for "generational" Storage Class Memory | Electrical shorting from etch residues; programme paused Sept 2025 | Storage Class Memory customers | 2025 (discontinued) | — |
| Custom ReRAM test chip (Infineon design) | Test chip designed by Infineon Technologies LLC to 4DS requirements; intended "third phase" after resistor devices and imec platform arrays | Design agreement US$4.5M over 15 months | Internal validation vehicle | Dec 2024; collaboration ended Sept 2025 | — |
| "Persistent DRAM-like" memory for AI | Positioning of the cell as high-bandwidth, high-endurance memory needing no refresh within its persistence window | Positioned for big data and neural-network workloads | AI processor makers | 2023 announcement | n/a — rram-info.com |
| Patent portfolio | 34 granted US patents developed in-house | Covers materials and cell architecture, e.g., a resistive memory device with a template layer (28th patent) | Licensees/acquirers | Latest grants FY2024 | Licensing/sale of IP |
Prospective software platform (via Jenesys — pending completion)
| Offering | Description | Capabilities | Target customer | Status | Pricing model |
|---|---|---|---|---|---|
| Distributed Autonomy Stack (Jenesys flagship) | Software layer enabling fleets of mixed unmanned vehicles to coordinate without a central command node | Edge-AI coordination across air, land, sea and space domains | Defence primes, government, autonomous-systems integrators | Commercial product per Jenesys; no disclosed revenue | Licensing/deployment (milestones reference contracted licensing revenue) |
| Integrated CIM/neuromorphic platform | Jenesys software and Edge-AI models integrated with PCMO ReRAM hardware for in-memory computing | Proposed post-completion activity | Edge-AI device makers, defence | Concept stage | — |
Commentary. The honest characterization is that 4DS owns one proven-at-60nm memory platform, one failed scaling programme, a patent estate, and (pending) a young software company with limited operating history. There is no flagship "product" in the commercial sense. The 60nm platform's value depends on whether mature-node fabs want a novel embedded NVM where embedded flash is entrenched, and the Jenesys stack's value depends on defence/autonomy customer adoption that has not yet been demonstrated publicly.
Financial Narrative
All figures A$ millions unless stated; fiscal years end 30 June. "Revenue" refers to revenue and other income from ordinary activities (primarily interest income), not trading revenue.
Income statement
Sources: Net loss FY2022–FY2024 from stoxray.com (ASX-filed data) and InvestSMART (FY2022 -6.7; FY2023 -5.8); FY2025 A$9,678,176 and FY2024 A$5,450,713 from Appendix 4E FY2025; FY2026 A$1,593,894 from Appendix 4E FY2026. FY2024 revenue implied. Operating loss (NOPBT) series from stoxray.com; column alignment on the source page is ambiguous, so treat as indicative. Gross profit, EBITDA and pre-tax income are not meaningful for a pre-revenue R&D company and are not separately disclosed in the sources retrieved. FY2021 net loss was approximately A$6.7M (InvestSMART).
EPS. Basic and diluted EPS are fractions of a cent in all years (aggregators show approximately -A$0.01 or smaller per share). Precise per-share figures are n/d in sources retrieved; refer to the respective annual reports. With ~2.06B shares in FY2026, the FY2026 loss implies roughly -0.08 cents per share (derived: 1.594 / ~2,000M weighted shares; weighted-average share count n/d, so indicative only).
Margins. Gross, operating, EBITDA and net margins are not meaningful (denominator is interest income). Revenue CAGR is not meaningful.
Commentary. The P&L is a pure R&D cost line. Losses ran at a steady A$5.5–6.7M a year through FY2022–FY2024 as the company funded successive imec Platform Lots and its Fremont lab. FY2025 was the peak-spend year (A$9.68M loss, +78% YoY) as it simultaneously ran the Fifth and Sixth Platform Lots and began paying Infineon under the US$4.5M design agreement. FY2026 shows an 84% reduction in loss to A$1.59M after the September 2025 development pause, the exit from imec and Infineon, executive resignations, and reductions in director and executive remuneration (Quartr FY2026 summary). The FY2026 loss is notably smaller than the FY2026 operating cash outflow (A$3.09M), implying non-cash credits or prior-period accruals (e.g., settlement of the imec payable, which was A$755k in May 2026) — the reconciliation is n/d in sources retrieved and should be checked in the FY2026 Annual Report.
Balance sheet
Sources: FY2022–FY2024 cash from stoxray.com / company quarterly reports (30 Jun 2022: A$5.234M; 30 Jun 2024: A$7.884M per Sep 2024 quarterly); FY2023 equity A$5,659k and debt A$54k from InvestSMART; FY2025 total assets and equity from financialfilings.com (Annual Report filed 28 Aug 2025); FY2025 and FY2026 statutory cash & equivalents (A$848,573 and A$432,191) from Quartr FY2026 summary; FY2026 Appendix 4C cash A$6.98M from June 2026 Quarterly Activity Report. Goodwill/intangibles: R&D is expensed and no acquisitions have been capitalized pre-Jenesys (zero assumed on the basis that the company describes patents as developed in-house; confirm in FY2026 accounts).
Net debt / working capital. The company is effectively debt-free (FY2023 debt of A$54k is likely lease-related). Net cash ≈ A$7.0M at 30 June 2026 (Appendix 4C basis). Working capital n/d.
Equity history. Accumulated losses reached ~A$69M by December 2024, against reported net assets of A$4.74M at that date (shareholder question at the 17 April 2025 EGM, Mayne Report). Equity rose to A$8.78M at 30 June 2025 after the A$6M placement and A$2M SPP.
Cash flow
Sources: stoxray.com (FY2022–FY2024 OCF and financing CF); financialfilings.com and Quartr (FY2025 OCF A$7.78M); Quartr FY2026 summary (FY2026 OCF A$3,093,973). Investing cash flows were immaterial (sub-A$0.25M) in years shown by aggregators; precise capex n/d. FY2025 gross equity raised was approximately A$8M (A$6M placement + A$2M SPP; transaction costs n/d).
Quarterly operating cash burn (A$ M), from Appendix 4C reports:
Sources: Sep 2024, Mar 2025, Sep 2025, Mar 2026 and Jun 2026 quarterly reports. The June 2026 quarter included the A$755k imec payment; R&D cash payments were A$772k for the quarter and A$1.669M year-to-date; business development A$75k (quarter) and A$210k (YTD). Cash at 31 December 2024 was A$4.625M.
Commentary. Cash burn has fallen from ~A$7.8M/year (FY2025) to ~A$3.1M/year (FY2026) and, excluding the one-off imec settlement, to well under A$1M per quarter. At 30 June 2026 the company had roughly 2+ years of runway at the reduced burn — but the Jenesys acquisition, new MD/CEO and software development programme will re-accelerate spending in FY2027. The ~A$5M raise (A$2M placement + ~A$2.9M rights issue at full subscription) was explicitly sized to fund integration and commercialization.
Ratios
Derivations: FY2023 ROE = -5.79 / 5.66; FY2025 ROE = -9.68 / 8.78; FY2025 ROA = -9.68 / 10.54; FY2023 D/E = 0.054 / 5.66. An aggregator (GuruFocus, December 2024) reported equity-to-assets of 0.95 and debt-to-equity of 0.03.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Revenue
| Segment | Contents | FY2024 revenue (AUD) | FY2025 revenue (AUD) | FY2026 revenue (AUD) | Margin | Source |
|---|---|---|---|---|---|---|
Memory technology R&D (sole segment) | Interface Switching ReRAM IP, Fremont lab, patents | n/d (implied ~33k) | 305,160 | 339,555 | n/m (loss-making) | Appendix 4E FY2025, FY2026 |
Revenue by Segment
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Memory technology segment revenue & other income (AUD K) | 33 | 305 | 340 |
Segment net loss after tax (AUD K) | -5,451 | -9,678 | -1,594 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue & other income (AUD Mn) | — | — | 0.033 | 0.305 | 0.340 |
Operating loss / NOPBT (AUD Mn) | -6.64 | -7.85 | -4.85 | — | — |
Net loss after tax (AUD Mn) | -6.73 | -5.79 | -5.45 | -9.68 | -1.59 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash incl. term deposits, per Appendix 4C (AUD Mn) | 5.23 | 5.60 | 7.88 | — | 6.98 |
Cash & cash equivalents, statutory balance sheet (AUD Mn) | 5.23 | 5.60 | 7.88 | 0.85 | 0.43 |
Total assets (AUD Mn) | — | — | — | 10.54 | — |
Total equity (AUD Mn) | — | 5.66 | — | 8.78 | — |
Total debt (AUD Mn) | — | 0.054 | — | — | — |
Goodwill & intangibles (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -5.39 | -4.71 | -4.73 | -7.78 | -3.09 |
Financing cash flow (AUD Mn) | 6.60 | 5.09 | 7.00 | — | — |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Key Financials
| Metric | Sep-2024 Q | Mar-2025 Q | Sep-2025 Q | Mar-2026 Q | Jun-2026 Q |
|---|---|---|---|---|---|
Net operating cash outflow (AUD Mn) | — | — | 0.971 | 0.229 | 1.426 |
Cash at quarter end (AUD Mn) | 6.312 | 9.081 | 9.1 | 8.47 | 6.98 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2023 | FY2025 |
|---|---|---|
ROE, net loss / closing equity (%) | -102 | -110 |
ROA, net loss / closing total assets (%) | — | -92 |
Debt / equity (x) | 0.01 | — |
Results by Region
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia — interest & other income (AUD K) | 33 | 305 | 340 |
Americas — revenue (AUD K) | 0 | 0 | 0 |
EMEA — revenue (AUD K) | 0 | 0 | 0 |
APAC ex-Australia — revenue (AUD K) | 0 | 0 | 0 |
Share Price
| Metric | Dec-2024 | Feb-2025 | Jun-2025 | Dec-2025 | Sep-2026 |
|---|---|---|---|---|---|
Share price, approximate (AUD) | 0.08 | 0.036 | 0.028 | 0.012 | 0.008 |
Capital Markets
| Metric | FY2026 | Oct-2026 |
|---|---|---|
Shares on issue (millions, approximate) | 2,060 | 3,055 |
Analyst Conclusions
Management guidance
No financial guidance. Management's stated outlook is to advance commercialization of the 60nm ReRAM platform in mature-node markets, especially India (Quartr FY2026 summary), and — on completion of Jenesys — to integrate Jenesys software and Edge-AI models with PCMO ReRAM hardware to target CIM and neuromorphic computing. Consensus growth expectations: none (no coverage).
Bull case (grounded in data above)
-
Real, validated asset at the right node for India. The 60nm megabit array is proven on imec's industrial platform, and India's A$25B+ fab programme is concentrated at 60–65nm; a single licensing or technology-transfer deal with one of the two conglomerates met in June 2026 could re-rate a company valued at ~A$25M.
-
Cost base reset and incentive alignment. Loss cut 84% to A$1.59M in FY2026; Jenesys vendors receive the bulk of upside only if contracted revenue reaches A$2M (24 months) and A$5M (36 months).
-
Platform optionality. CIM/neuromorphic computing is a natural fit for analog-capable ReRAM; pairing it with a defence-autonomy software stack gives 4DS a demonstrable end-application rather than a bare memory cell, and the HGST JDA remains a potential strategic validator.
Bear case (grounded in data above)
-
Core thesis already failed. The 20nm Sixth Platform Lot failure ended the Storage Class Memory strategy; the 60nm "fallback" competes with entrenched embedded flash and with Weebit Nano, which has TI/onsemi/DB HiTek licences, three tape-outs and A$168M cash.
-
Unrelated pivot with heavy dilution. The share count rises ~48% to ~3.06B, with up to 350M more shares, to buy a young software company whose IP clarity and operating history are still to be demonstrated.
-
Capability hollowing. No CTO, no fab partner (imec exited), no blue-chip collaborator other than an unconfirmed HGST renewal, and a long-tenured three-person board under an Executive Chairman.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | What to watch |
|---|---|---|
| Oct 2026 | Jenesys completion announcement; Jaspal Sarai appointed MD & CEO | Final share count; rights-issue take-up and shortfall placement |
| 16 Oct 2026 (scheduled) | Annual Report to Shareholders | Remuneration, auditor, top-20 holders |
| Oct 2026 | September 2026 quarterly 4C | Post-raise cash, burn rate with Jenesys consolidated |
| Nov 2026 | AGM | Board renewal; any further shareholder nominations |
| H2 2026 | HGST JDA renewal outcome | Confirmation or loss of last blue-chip partner |
| H2 2026 – H1 2027 | India: binding licence/technology-transfer/R&D agreement | First commercial validation of 60nm platform |
| 2,027 | First contracted Jenesys revenue | Progress toward A$2M milestone (24 months) |
| Feb 2027 | Half-year FY2027 accounts | Goodwill recognized on Jenesys; integration costs |
Concluding analyst verdict
4DS Memory is no longer the company most of its shareholders invested in. For a decade it was a binary bet that a novel PCMO perovskite memory cell could be scaled below 20nm into a "generational" Storage Class Memory; that bet was settled negatively in 2025 when the Sixth Platform Lot shorted out because of etch residues, the company paused development, and its CTO, CSO, imec and Infineon all exited within weeks. What remains is a genuinely differentiated but commercially unproven 60nm ReRAM platform, a 34-patent US estate, an annually renewed (and currently unconfirmed) HGST relationship, roughly A$7M of cash before the latest raise, and a dramatically lower cost base.
Management's response — an India-focused mature-node licensing pathway plus the scrip acquisition of Jenesys — is coherent in narrative terms (hardware plus software for computing-in-memory and Edge-AI) but thin in evidence. No licence, customer, foundry qualification or Jenesys revenue has yet been disclosed, while the share base expands by roughly half and governance remains concentrated in a long-tenured three-person board led by an Executive Chairman. The closest comparable, Weebit Nano, shows what success in embedded ReRAM licensing looks like — major IDM licensees, customer tape-outs and a balance sheet more than twenty times larger — and highlights how far 4DS is from that position.
At an enterprise value of roughly A$10–20M, the market is pricing 4DS as an option on either an Indian licensing deal or Jenesys traction. That option is real but low-probability, and its exercise will almost certainly require further dilutive capital. We would characterize the security as a speculative special situation suitable only for risk capital, with the investment case hinging on three verifiable near-term proofs: formal Jenesys completion with a credible operating plan, a binding India agreement, and confirmation of the HGST JDA. Absent at least one of these within 12 months, the balance of evidence favours the bear case.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Background (as disclosed) | Source |
|---|---|---|---|---|
David McAuliffe | Executive Chairman (Executive Director) | Director since 7 Dec 2015 | B.Pharm, LLB (Hons); co-founder-era director; leads strategy, capital raising and India business development | Alpha Spread; InvestSMART; company releases |
Dr Guido Arnout | Non-Executive Director | Since 7 Dec 2015 (previously CEO & Managing Director, at least through 2021) | Over 30 years commercializing electronics/EDA technologies (Annual Report FY2021); re-elected at Nov 2024 AGM; lodged an Appendix 3Y on 8 Sep 2026 | Annual Report FY2021; AGM notice Oct 2024; Listcorp |
Howard Digby | Non-Executive Director | Since 7 Dec 2015 | Former Executive Editor of WA Business News; company director, adviser and investor with experience in M&A and reverse takeovers | Motley Fool director profile |
Executive Leadership Team
| Name | Role | Status | Source |
|---|---|---|---|
David McAuliffe | Executive Chairman (de facto chief executive) | Current | Company releases |
Jaspal Sarai | MD & CEO (designate) | On completion of Jenesys | 4DS to Acquire Jenesys |
Peter Webse | Company Secretary (outsourced, Governance Corporate) | Since May 2015 | Motley Fool; company releases |
Dr Ting Yen | Chief Technology Officer | Resigned Sept 2025 | SmallCaps; rram-info.com |
Peter Himes | Chief Strategy Officer | Joined FY2024; resigned Sept 2025 | Chairman's address Nov 2023; SmallCaps |
Seshubabu Desu | Former senior technical executive (title n/d) | Historical | IBISWorld |
Governance Overview
| Attribute | Status |
|---|---|
Board size | 3 (pre-completion); 4 expected post-completion |
Independence | At most 2 of 3 non-executive; independence of Dr Arnout (former CEO) is questionable under ASX Corporate Governance Principles |
Chair / CEO separation | No — Executive Chairman model; separation expected to improve when an MD & CEO is appointed |
Committees | Given board size, audit/remuneration/nomination functions are likely performed by the full board (per FY2026 Corporate Governance Statement, 28 Aug 2026 — details n/d) |
Board tenure | All three directors appointed 7 Dec 2015 (~11 years), raising board-renewal concerns |
Gender diversity | 0 female directors (based on listed directors) |
Competitive Landscape
Competitors by Segment
| Domain | Competitor | Type | Relative positioning vs 4DS |
|---|---|---|---|
Embedded ReRAM IP | Weebit Nano (ASX: WBT) | Listed ReRAM IP licensor | Far ahead: licensees include DB HiTek, onsemi and Texas Instruments; three customer tape-outs; FY2026 revenue A$15.3M |
Embedded ReRAM IP | Crossbar Inc. (US, private) | Filamentary ReRAM IP | Established ReRAM licensor; financials n/d |
Embedded ReRAM IP | Intrinsic Semiconductor Technologies (UK, private) | Silicon-oxide ReRAM | Early-stage; n/d |
Foundry embedded RRAM | TSMC | Foundry offering embedded RRAM at mature/advanced nodes | Integrated into foundry PDKs; structural advantage |
MCU with RRAM | Infineon Technologies (former partner) | IDM using RRAM in automotive MCUs (with TSMC) | Customer turned non-partner; potential competitor in automotive eNVM |
MRAM | Everspin Technologies (NASDAQ: MRAM) | Discrete and embedded MRAM | Commercial: 2025 revenue US$55.2M; 238 design wins |
MRAM | Avalanche Technology (private) | STT-MRAM | Defence/space niche — overlaps with Jenesys's defence target market |
Embedded flash / FeRAM | Renesas, Microchip, Fujitsu, Infineon | Incumbent eNVM | Dominant at 60nm — the node 4DS now targets |
Ferroelectric memory | Ferroelectric Memory Company (FMC, private) | FeFET/FeRAM | Emerging NVM alternative |
Storage Class Memory | Micron, SK hynix, Samsung, Kioxia | Memory majors | Abandoned/dominant; Intel exited Optane (3D XPoint) — evidence of SCM market difficulty |
Neuromorphic / Edge-AI (post-Jenesys) | BrainChip (ASX: BRN) | Neuromorphic IP | Listed Australian peer in Edge-AI hardware |
Autonomous systems software (post-Jenesys) | Shield AI, Anduril (Lattice), Palantir; ASX peer DroneShield (counter-drone) | Autonomy/defence software | Large, well-funded incumbents |
Peer Comparison FY2026
| Metric | 4DS Memory (FY2026, A$) | Weebit Nano (FY2026, A$) | Everspin (FY2025, US$) |
|---|---|---|---|
Revenue | 0.34M (interest/other) | 15.3M (licensing + NRE) | 55.2M |
Revenue growth | +11% | +246% | +9.5% |
Gross margin | n/m | — | 51.2% |
Net result | -1.59M | -54.9M | -0.6M (GAAP) |
Cash | 6.98M (4C basis) | 168.3M | 44.5M |
R&D intensity | n/m (pre-revenue) | n/d (quarterly R&D ~A$4.6M) | — |
Commercial status | Pre-commercial; no licensees | Licensees incl. TI, onsemi, DB HiTek; 3 tape-outs | Volume production; 238 design wins in 2025 |
Recent Developments
--



